Connect Biopharma (ADR) (CNTB)
Develops rademikibart for asthma and COPD outside Greater China.
$2.79
Pre-market+0.02 (+0.72%)
At close$2.77(+17.16%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.27
Revenue estimate
$114.7K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '24Sep '24Mar '25Aug '25Mar '26May '26Aug '26Nov '26
Reported−$0.07$0.02−$0.06−$0.23−$0.27−$0.34−$0.27Pending
Estimate−$0.03−$0.03−$0.27−$0.22−$0.30−$0.29−$0.31−$0.27
Surprise−131.7%+167.5%+78.7%−4.5%+10.0%−17.2%+14.3%—
RevenueReportedEstimate
Apr '24Sep '24Mar '25Aug '25Mar '26May '26Aug '26Nov '26
Reported—$3.3M$261.9K$6.7K—$24.4K$2.7MPending
Estimate$2.9M$2.9M——$538—$743.3K$114.7K
Surprise—+12.5%————+269.7%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.27 | — | — |
| Aug 2026 | −$0.31 | −$0.27 | +14.3% |
| May 2026 | −$0.29 | −$0.34 | −17.2% |
| Mar 2026 | −$0.30 | −$0.27 | +10.0% |
| Aug 2025 | −$0.22 | −$0.23 | −4.5% |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | |||
| Mar 2025 | |||
| Sep 2024 | |||
| Apr 2024 | |||
| Sep 2023 | |||
| Apr 2023 | |||
| Sep 2022 | |||
| Mar 2022 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.27 | — | — | $114.7K | — | — | — |
| Aug 12, 2026 | −$0.31 | −$0.27 | +14.3% | $743.3K | $2.7M | +269.7% | +9.0% |
| May 12, 2026 | −$0.29 | −$0.34 | −17.2% | — | $24.4K | — | −8.6% |
| Mar 31, 2026 | −$0.30 | −$0.27 | +10.0% | $538 | — | — | +3.8% |
| Aug 13, 2025 | −$0.22 | −$0.23 | −4.5% | — | $6.7K | — | −8.9% |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | |||||||
| Mar 31, 2025 | |||||||
| Sep 5, 2024 | |||||||
| Apr 16, 2024 | |||||||
| Sep 12, 2023 | |||||||
| Apr 11, 2023 | |||||||
| Sep 13, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Aug 31, 2021 | |||||||
| Mar 19, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||